PTCH2, patched 2, 8643

N. diseases: 114; N. variants: 4
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.170 Biomarker group BEFREE We conclude that like Ptch1, Ptch2 exerts a tumor-suppressive function in BCC cells, and that after targeting of both paralogs, ligand-independent activation of the Hh pathway contributes to tumor growth. 29869097 2018
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.170 Biomarker group BEFREE Moreover, increased expression of cyclin A was observed in PTCs with a tumor size >2 cm compared with PTCs ≤2 cm (1.2 vs 0.6%). 22457234 2012
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.170 AlteredExpression group BEFREE More than half of the tumor samples showed involvement of Hh signaling or pathway activation either by expression of transcription factors and Hh ligands or by overexpression of Indian HH/sonic HH and the receptor-encoding patched homolog 1/patched homolog 2. 21666490 2011
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.170 Biomarker group BEFREE Patched-2, RIZ1 and KIF1B are novel oncosuppressor genes located at 1p and involved in different kinds of tumors. 15711769 2005
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.170 AlteredExpression group BEFREE We conclude that Patched 2 is expressed, but not frequently mutated, in high stage neuroblastomas and is therefore not likely to be involved in the genesis of this tumor. 10762630 2000
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.170 Biomarker group BEFREE Isolation and characterization of human patched 2 (PTCH2), a putative tumour suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome 1p32. 9931336 1999
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.170 Biomarker group BEFREE The genomic organization is similar to PTCH1 with 22 exons and, by radiation hybrid mapping, PTCH2 has been localized to chromosome 1p33-34, a region often lost in a variety of tumors. 10029063 1999
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.170 Biomarker group HPO